Dolby Laboratories, Inc.
US ˙ NYSE ˙ US25659T1079

SecurityDLB / Dolby Laboratories, Inc.
InstitutionAxa S.a.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Axa S.a. closes position in DLB / Dolby Laboratories, Inc.

On November 14, 2025 - Axa S.a. filed a 13F-HR form disclosing ownership of 0 shares of Dolby Laboratories, Inc. (US:DLB) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 76,358 shares of Dolby Laboratories, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 0 -100.00 0
2025-08-14 2025-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 76,358 0 0.00 5,670 -7.53 0.0163
2025-05-15 2025-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 76,358 0 0.00 6,132 2.83 0.0201
2025-02-14 2024-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 76,358 65,040 574.66 5,964 588.57 0.0181
2024-11-14 2024-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 11,318 11,318 866 0.0026
2022-08-15 2022-06-30 13F Dolby Laboratories COM CL A 25659T107 0 -12,900 -100.00 0 -100.00
2023-02-14 2022-03-31 13F/A-1 Dolby Laboratories COM CL A 25659T107 12,900 6,800 111.48 1,009 73.67 0.0029
2022-05-13 2022-03-31 13F Dolby Laboratories COM CL A 25659T107 12,900 6,800 1,009 0.0029
2022-02-14 2021-12-31 13F Dolby Laboratories COM CL A 25659T107 6,100 -67,600 -91.72 581 -91.04 0.0015
2021-11-15 2021-09-30 13F Dolby Laboratories COM CL A 25659T107 73,700 0 0.00 6,486 -10.46 0.0182
2021-08-13 2021-06-30 13F/A-1 Dolby Laboratories COM CL A 25659T107 73,700 -22,800 -23.63 7,244 -23.96 0.0204
2021-08-13 2021-06-30 13F Dolby Laboratories COM CL A 25659T107 73,700 -22,800 7,244 0.0122
2021-05-14 2021-03-31 13F Dolby Laboratories COM CL A 25659T107 96,500 96,500 9,526 0.0290
2020-08-14 2020-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 0 -20,100 -100.00 0 -100.00
2021-02-12 2020-03-31 13F/A-2 DOLBY LABORATORIES COM CL A 25659T107 20,100 0 0.00 1,090 -21.19 0.0054
2020-06-15 2020-03-31 13F/A-1 DOLBY LABORATORIES COM CL A 25659T107 20,100 0 1,090 0.0055
2020-05-15 2020-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 20,100 0 1,090 3,031.3087
2021-02-12 2019-12-31 13F/A-1 DOLBY LABORATORIES COM CL A 25659T107 20,100 -10,500 -34.31 1,383 -30.08 0.0056
2020-02-18 2019-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 20,100 -10,500 1,383 5,631.1031
2021-02-12 2019-09-30 13F/A-1 DOLBY LABORATORIES COM CL A 25659T107 30,600 10,500 52.24 1,978 52.39 0.0079
2019-11-14 2019-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 30,600 10,500 1,978 7,882.4559
2021-02-12 2019-06-30 13F/A-1 DOLBY LABORATORIES COM CL A 25659T107 20,100 0 0.00 1,298 2.53 0.0051
2019-08-13 2019-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 20,100 0 1,298 5,090.2101
2019-05-14 2019-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 20,100 0 0.00 1,266 1.85 0.0049
2019-02-13 2018-12-31 13F DOLBY LABORATORIES COM 25659T107 20,100 0 0.00 1,243 -11.59 0.0054
2018-11-08 2018-09-30 13F DOLBY LABORATORIES COM 25659T107 20,100 -4,900 -19.60 1,406 -8.82 0.0052
2018-08-13 2018-06-30 13F DOLBY LABORATORIES COM 25659T107 25,000 1,000 4.17 1,542 1.11 0.0059
2018-05-14 2018-03-31 13F DOLBY LABORATORIES COM 25659T107 24,000 24,000 1,525 0.0061
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.